| Application no. and date | 18821779.8 (espacenet) (Federated) (European Patent Register), 20181121 | | Patent/reg. no. and date | DK/EP 3713919, 20230802 | | Publication date | 20200930 | | Priority no. and date | US 201762589822 P, 20171122, US 201862691709 P, 20180629 | | EP pub. no. and date |
EP 3713919 20200930 | | Effective date | | | Applicant/owner | Agios Pharmaceuticals, Inc., 88 Sidney Street
Cambridge, MA 02139, US | | Applicant ref. no. | P82736DK01 | | Inventor | SIZEMORE, Jacob, P., 8 Vista Drive
Shrewsbury
MA 01545, US,
MIRMEHRABI, Mahmoud, 36 Roxbury Crescent
Halifax
Nova Scotia B3M 4T1, CA,
SU, Yeqing, 2225 Monastery Lane Apt 310
Halifax
Nova Scotia B3L 4R1, CA,
GUO, Liting, Qinshui Langting Blvd. 18
2 HongFan Road
Suzhou Industrial Park
Suzhou 215000, CN | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/4709 (2006.01) , A61P 7/06 (2006.01) , C07D 215/36 (2006.01) | | Title | KRYSTALLINSKE FORMER AF N-(4-(4-(CYCLOPROPYLMETHYL)PIPERAZIN-1-CARBONYL)PHENYL)QUINOLIN-8-SULFONAMID | | Int. application no. | US2018062197 | | Int. publication no. | WO2019104134 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
